心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 EHRA专家共识指南：常规起搏器和植入式心律转复除颤器的最佳植入技术

2021-04-20 欧洲心律学会 Europace.2021 Apr 20;euaa367.

心脏起搏器

2021年4月，欧洲心律学会(EHRA)发布了常规起搏器和植入式心律转复除颤器的最佳植入技术共识指南。随着全球范围内植入设备的不断增加，需要培训常规起搏器和植入式心律转复除颤器的植入技术。本文主要通过

中文标题：

2021 EHRA专家共识指南：常规起搏器和植入式心律转复除颤器的最佳植入技术

英文标题：

EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators

发布机构：

欧洲心律学会

发布日期：

2021-04-20

简要介绍：

2021年4月，欧洲心律学会(EHRA)发布了常规起搏器和植入式心律转复除颤器的最佳植入技术共识指南。随着全球范围内植入设备的不断增加，需要培训常规起搏器和植入式心律转复除颤器的植入技术。本文主要通过制定设备植入标准，为常规起搏器和植入式心律转复除颤器的最佳植入技术提供指导。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 EHRA专家共识指南：常规起搏器和植入式心律转复除颤器的最佳植入技术.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4377b1c00209190d, title=2021 EHRA专家共识指南：常规起搏器和植入式心律转复除颤器的最佳植入技术, enTitle=EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators, guiderFrom=Europace.2021 Apr 20;euaa367., authorId=0, author=, summary=2021年4月，欧洲心律学会(EHRA)发布了常规起搏器和植入式心律转复除颤器的最佳植入技术共识指南。随着全球范围内植入设备的不断增加，需要培训常规起搏器和植入式心律转复除颤器的植入技术。本文主要通过, cover=https://img.medsci.cn/2021430/1619717007431_2020535.jpg, journalId=0, articlesId=null, associationId=206, associationName=欧洲心律学会, associationIntro=欧洲心律学会（EHRAE,uropean Heart Rhythm Association)是欧洲心脏病学会的分支，致力于心律失常的预防与管理，以减少心律失常对患者的影响,减少心源性猝死。官方杂志《欧洲心律失常杂志》影响因子为1.839, copyright=0, guiderPublishedTime=Tue Apr 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月，欧洲心律学会(EHRA)发布了常规起搏器和植入式心律转复除颤器的最佳植入技术共识指南。随着全球范围内植入设备的不断增加，需要培训常规起搏器和植入式心律转复除颤器的植入技术。本文主要通过制定设备植入标准，为常规起搏器和植入式心律转复除颤器的最佳植入技术提供指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2413, tagName=心脏起搏器)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2413, guiderKeyword=心脏起搏器, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9128, appHits=374, showAppHits=0, pcHits=1793, showPcHits=8754, likes=5, shares=34, comments=29, approvalStatus=1, publishedTime=Fri Apr 30 01:23:50 CST 2021, publishedTimeString=2021-04-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 30 01:23:38 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:45:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EHRA专家共识指南：常规起搏器和植入式心律转复除颤器的最佳植入技术.pdf)])
2021 EHRA专家共识指南：常规起搏器和植入式心律转复除颤器的最佳植入技术.pdf
下载请点击：
评论区 (26)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194392, encodeId=5146119439277, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Thu Feb 17 11:30:36 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190089, encodeId=e87711900897a, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f874706080, createdName=1911395912, createdTime=Fri Feb 04 09:17:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182223, encodeId=90061182223a7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5aec5112847, createdName=1461bde6m98暂无昵称, createdTime=Sat Jan 08 15:22:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080126, encodeId=edd41080126fc, content=要加油看书, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ace5622459, createdName=ms3000001281480633, createdTime=Tue Dec 14 23:22:09 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072985, encodeId=be2910e29852b, content=不错，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Nov 22 22:14:32 CST 2021, time=2021-11-22, status=1, ipAttribution=)]
    2022-02-17 恒心

    有没有中文版

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1194392, encodeId=5146119439277, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Thu Feb 17 11:30:36 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190089, encodeId=e87711900897a, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f874706080, createdName=1911395912, createdTime=Fri Feb 04 09:17:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182223, encodeId=90061182223a7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5aec5112847, createdName=1461bde6m98暂无昵称, createdTime=Sat Jan 08 15:22:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080126, encodeId=edd41080126fc, content=要加油看书, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ace5622459, createdName=ms3000001281480633, createdTime=Tue Dec 14 23:22:09 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072985, encodeId=be2910e29852b, content=不错，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Nov 22 22:14:32 CST 2021, time=2021-11-22, status=1, ipAttribution=)]
    2022-02-04 1911395912

    好东西

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194392, encodeId=5146119439277, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Thu Feb 17 11:30:36 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190089, encodeId=e87711900897a, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f874706080, createdName=1911395912, createdTime=Fri Feb 04 09:17:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182223, encodeId=90061182223a7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5aec5112847, createdName=1461bde6m98暂无昵称, createdTime=Sat Jan 08 15:22:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080126, encodeId=edd41080126fc, content=要加油看书, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ace5622459, createdName=ms3000001281480633, createdTime=Tue Dec 14 23:22:09 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072985, encodeId=be2910e29852b, content=不错，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Nov 22 22:14:32 CST 2021, time=2021-11-22, status=1, ipAttribution=)]
    2022-01-08 1461bde6m98暂无昵称

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1194392, encodeId=5146119439277, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Thu Feb 17 11:30:36 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190089, encodeId=e87711900897a, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f874706080, createdName=1911395912, createdTime=Fri Feb 04 09:17:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182223, encodeId=90061182223a7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5aec5112847, createdName=1461bde6m98暂无昵称, createdTime=Sat Jan 08 15:22:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080126, encodeId=edd41080126fc, content=要加油看书, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ace5622459, createdName=ms3000001281480633, createdTime=Tue Dec 14 23:22:09 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072985, encodeId=be2910e29852b, content=不错，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Nov 22 22:14:32 CST 2021, time=2021-11-22, status=1, ipAttribution=)]
    2021-12-14 ms3000001281480633

    要加油看书

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1194392, encodeId=5146119439277, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FB3TvKpvrtujQ2N7qVxKiaiaCaWyEhaVeeYp60ibK2Ydhrtsg2JSUm4mjfN0P0lPJP9VhGtZFFFUKuJNbPOibvDPkQ/132, createdBy=f4fe2307331, createdName=恒心, createdTime=Thu Feb 17 11:30:36 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190089, encodeId=e87711900897a, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f874706080, createdName=1911395912, createdTime=Fri Feb 04 09:17:27 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182223, encodeId=90061182223a7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5aec5112847, createdName=1461bde6m98暂无昵称, createdTime=Sat Jan 08 15:22:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080126, encodeId=edd41080126fc, content=要加油看书, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ace5622459, createdName=ms3000001281480633, createdTime=Tue Dec 14 23:22:09 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072985, encodeId=be2910e29852b, content=不错，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Nov 22 22:14:32 CST 2021, time=2021-11-22, status=1, ipAttribution=)]
    2021-11-22 仁术2021

    不错，学习了。

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2016 置入心脏起搏器和植入式心脏除颤器的老年患者的管理意见书

国外心血管相关专家小组（统称） · 2016-08-29

拓展阅读

2016 置入心脏起搏器和植入式心脏除颤器的老年患者的管理意见书

国外心血管相关专家小组（统称） · 2016-08-29

2022 BHRS专家共识声明：无导联起搏系统的最佳使用和临床应用

英国心律学会(BHRS,British Heart Rhythm Society) · 2022-08-01